Login / Signup

Bone marrow-derived mesenchymal stem cells inhibit NK cell function via Tim-3/galectin-9 in multiple myeloma patients.

Zhao-Yun LiuNan-Hao MengPan-Pan CaoYue JiaHao WangYun-He ZhangHui LiuWenhui Lei
Published in: Clinical and translational medicine (2023)
Keyphrases
  • bone marrow
  • multiple myeloma
  • nk cells
  • end stage renal disease
  • newly diagnosed
  • mesenchymal stem cells
  • prognostic factors
  • patient reported outcomes